Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance-A Meta-Analysis

被引:10
作者
Aalaei-Andabili, Seyed Hossein [1 ]
Behnava, Bita [2 ,3 ]
Salimi, Shima [2 ,3 ]
Sharafi, Heidar [2 ,3 ]
Alavian, Seyed Moayed [2 ,4 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Dept Immunol, Mol Immunol Res Ctr, Tehran, Iran
[2] Middle East Liver Dis Ctr, Tehran, Iran
[3] Baqiyatallah Univ Med Sci, Baqiyatallah Res Ctr Gastroenterol & Liver Dis BR, Tehran, Iran
[4] Iran Hepatitis Network IHN, Tehran, Iran
关键词
Hepatitis C; IL28B Protein; Human; Meta-Analysis; Genotype; GENOME-WIDE ASSOCIATION; RIBAVIRIN THERAPY; GENETIC-VARIATION; IL28B SNP; INFECTION; POLYMORPHISMS; ALPHA-2A;
D O I
10.5812/hepatmon.15895
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Recent genome wide association studies (GWAS) have shown important roles of single nucleotide polymorphisms (SNP) near region of interleukin B 28 (IL28B) gene in spontaneous and drug-induced clearance of hepatitis C virus (HCV) in genotype 1 HCV infection. Objectives: This meta-analysis was designed to determine the world-wide distribution patterns of IL28B genotypes and alleles, and to find possible linkages between IL28B and HCV genotypes. Patients and Methods: Manual and electronic databases were searched. Critical appraisal was performed. According to the results of heterogeneity tests, we used fix/random model for the analysis. The data concerning patients' ethnicity and HCV genotypes were analyzed by using statistical analysis software. Results: A total of 255 articles were found. After article review and quality assessment, 50 studies, including 18662 patients and 1313 healthy subjects, were analyzed. Presence of HCV genotype 3 versus genotype 1 was significantly associated with a higher frequency of CC genotype and C allele, with an odds ratio (OR) of 1.68 (95% CI: 1.44-1.99) and 1.49 (95% CI: 1.33-1.67), respectively. Prevalence of the rs12979860 CC genotype among genotype 1 HCV infected patients of Asian ethnicity was 69.48% (95% CI: 65.20-73.77), which was significantly higher than its prevalence [33.27% (95% CI: 28.88-37.67)] in the Caucasian genotype 1 HCV infected patients. Prevalence of rs12979860 TT genotype in the African-American genotype 1 HCV infected patients was the highest [36.20% (95% CI: 32.91-39.49)], and significantly different compared to all other ethnicities. Conclusions: There were significant linkages between HCV genotypes and IL28B genotypes/alleles. Patients with a favorable IL28B and genotypes 1 and 4 HCV infection stand a better chance to clear HCV in the acute phase.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Association between IL28B Polymorphisms and Outcomes of Hepatitis B Virus Infection: A meta-analysis
    Zhao, Jingyu
    Zhang, Xinyue
    Fang, Liwei
    Pan, Hong
    Shi, Jun
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [42] Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis
    Slavenburg, Serena
    Weggelaar, Ines
    van Oijen, Martijn G. H.
    Drenth, Joost P. H.
    ANTIVIRAL THERAPY, 2009, 14 (08) : 1139 - 1148
  • [43] Role of Interleukin-28B Polymorphisms in the Treatment of Hepatitis C Virus Genotype 2 Infection in Asian Patients
    Yu, Ming-Lung
    Huang, Chung-Feng
    Huang, Jee-Fu
    Chang, Ning-Chia
    Yang, Jeng-Fu
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Li, Yi-Ning
    Wu, Mei-Shin
    Dai, Chia-Yen
    Juo, Suh-Hang Hank
    Chuang, Wan-Long
    HEPATOLOGY, 2011, 53 (01) : 7 - 13
  • [44] Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance
    Asthana, Manu
    Sahu, Sushil Kumar
    Kumar, Amit
    Mohanty, Suchitra
    Chakrabarti, Sudipta
    Das, Piyanki
    Chattopadhya, Nabanita Roy
    Chatterjee, Koustav
    Singh, Shivaram Prasad
    Rajasubramaniam, Shanmugam
    Choudhuri, Tathagata
    CURRENT DRUG METABOLISM, 2018, 19 (03) : 215 - 223
  • [45] Distribution of IL28B rs12979860 and rs8099917 Genotypes in Patients with Chronic Hepatitis C Virus Infection in Tianjin, China
    Qiao, Kunyan
    Trieu, Congdoanh
    Huo, Zhixiao
    Du, Yanan
    Hou, Wei
    CLINICAL LABORATORY, 2018, 64 (04) : 543 - 550
  • [46] Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis
    Kong, Ling-Na
    Qin, Bo
    Ma, Qian
    Li, Lin
    Yao, Yu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (07) : 1387 - 1395
  • [47] Interleukin-28B Polymorphisms Are Associated With Histological Recurrence and Treatment Response Following Liver Transplantation in Patients With Hepatitis C Virus Infection
    Charlton, Michael R.
    Thompson, Alexander
    Veldt, Bart J.
    Watt, Kym
    Tillmann, Hans
    Poterucha, John J.
    Heimbach, Julie K.
    Goldstein, David
    McHutchison, John
    HEPATOLOGY, 2011, 53 (01) : 317 - 324
  • [48] Role of Interleukin-28B Polymorphism as a Predictor of Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Triple Therapy: A Systematic Review and Meta-Analysis
    Bota, Simona
    Sporea, Ioan
    Sirli, Roxana
    Neghina, Adriana Maria
    Popescu, Alina
    Strain, Mihnea
    CLINICAL DRUG INVESTIGATION, 2013, 33 (05) : 325 - 331
  • [49] Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection
    Grebely, Jason
    Petoumenos, Kathy
    Hellard, Margaret
    Matthews, Gail V.
    Suppiah, Vijayaprakash
    Applegate, Tanya
    Yeung, Barbara
    Marks, Phillipa
    Rawlinson, William
    Lloyd, Andrew R.
    Booth, David
    Kaldor, John M.
    George, Jacob
    Dore, Gregory J.
    HEPATOLOGY, 2010, 52 (04) : 1216 - 1224
  • [50] Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis
    de la Fuente, Sara
    Citores, Maria-Jesus
    Duca, Ana
    Cisneros, Elisa
    Banos, Isolina
    Vilches, Carlos
    Cuervas-Mons, Valentin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 17 (02) : 217 - 223